000			03298nam a22003977a 4500
999			_c12258 _d12258
001			MT 2022 0022
003			PILC
005			20240720153242.0
008			220407b xxu||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _erda
041			_aenglish
050			_aMT 2022 0022
245			_aCovid-19 challenges and associated implemented measures of blood banks : _ba systematic review / _cKieth Ken S. Amoguis, Ma. Edith Alegrine T. Booth, Daniel B. Caballero, Kyle Edison A. Dela Cruz, Michelle A. Ortiz Luis, Aleck Vianca S. Perez, Chlaritz T. Sebuala; Normel C. Ardave.
260			_aFairview, Quezon City: _bSchool of Medical Technology, FEU-NRMF, _c2022.
300			_a89 pages: _billustrations, tables; _c28 cm.
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes appendices and bibliographical references.
520			_aAbstract: SARS-CoV-2 has presented many challenges ranging from health to economic issues. The healthcare sector was particularly affected, straining its performance and resources. Blood banking facilities were faced with safety issues for donors, patients and staff, as well as compromised supply and demand for blood products brought by the COVID-19 Pandemic. Hence, this study aimed to determine the growing concerns as well as corresponding implemented measures of different blood banking laboratories worldwide. Based on the PRISMA framework, this study systematically searched and reviewed 50 relevant literatures from PubMed, Sciencedirect, ProQuest and ClinicalKey to identify the concerns of blood banking facilities and the associated measures implemented in response to the pandemic, And found that being updated and adhering to safety and security protocols, and having staff equipped with PPEs, educated and trained with safety protocols were important in addressing safety issues in blood banks. In maintaining blood supply, measures of increasing the donor recruitment by setting programs and strategies encouraging blood donation, and decreasing the utilization of blood products by canceling or postponing elective surgeries were commonly undertaken. In addressing the demand for COVID-19 Convalescent Plasma (CCP) treatment, different organizations and agencies regulate blood banking functions in order to allow CCP treatment. Lastly, to prevent blood wastage due to decreased blood demand, coordination with other blood banks was needed to balance the supply. The implications of the detailed concerns and measures may serve as a reference for other blood banking facilities to adopt in their practice and operations in dealing with similar challenges.
521			_aTHMT
650			_atransfusion medicine
650			_aconvalescent plasma therapy
650			_asafety protocol
650			_ablood supply
650			_ablood product demand
700			_aAmoguis, Keith Ken S. _eauthor
700			_aBooth, Ma. Edith Alegrine T. _eauthor
700			_aCaballero, Daniel B. _eauthor
700			_aDela Cruz, Kyle Edison A. _eauthor
700			_aOrtiz Luis, Michelle A. _eauthor
700			_aPerez, Aleck Vianca S. _eauthor
700			_aSebuala, Chlaritz T. _eauthor
700			_aAdarve, Normel C., RMT _eadviser
942			_2lcc _cRU